2021
DOI: 10.1021/acscentsci.0c01708
|View full text |Cite
|
Sign up to set email alerts
|

Discovery of Cyclic Peptide Ligands to the SARS-CoV-2 Spike Protein Using mRNA Display

Abstract: The COVID-19 pandemic, caused by SARS-CoV-2, has led to substantial morbidity, mortality, and disruption globally. Cellular entry of SARS-CoV-2 is mediated by the viral spike protein, and affinity ligands to this surface protein have the potential for applications as antivirals and diagnostic reagents. Here, we describe the affinity selection of cyclic peptide ligands to the SARS-CoV-2 spike protein receptor binding domain (RBD) from three distinct libraries (in excess of a trillion molecules each) by mRNA dis… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
52
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 62 publications
(53 citation statements)
references
References 58 publications
0
52
0
1
Order By: Relevance
“… [1] , [2] , [3] , [4] , [5] , [6] , [7] , [8] , [9] , [10] , [11] , [12] , [13] , [14] , [15] , [16] , [17] , [18] , [19] , [20] , [21] , [22] , [23] , [24] , [25] , [26] , [27] , [28] , [29] , [30] , [31] , [32] , [33] , [34] , [35] , [36] , [37] , [38] , [39] , [40] , [41] , [42] , [43] , [44] , [45] , [46] , [47] , [48] , [49] , [50] , [51] , [52] , [53] , [54] , [55] , [56] , [57] , [58] , [59] , [60] , [61] , [62] , [63] , [64] , [65] , [66] , [67] , [68] , [69] , [70] , [71] , [72] ...…”
Section: Uncited Referencesunclassified
“… [1] , [2] , [3] , [4] , [5] , [6] , [7] , [8] , [9] , [10] , [11] , [12] , [13] , [14] , [15] , [16] , [17] , [18] , [19] , [20] , [21] , [22] , [23] , [24] , [25] , [26] , [27] , [28] , [29] , [30] , [31] , [32] , [33] , [34] , [35] , [36] , [37] , [38] , [39] , [40] , [41] , [42] , [43] , [44] , [45] , [46] , [47] , [48] , [49] , [50] , [51] , [52] , [53] , [54] , [55] , [56] , [57] , [58] , [59] , [60] , [61] , [62] , [63] , [64] , [65] , [66] , [67] , [68] , [69] , [70] , [71] , [72] ...…”
Section: Uncited Referencesunclassified
“… 24 27 There are several SARS-CoV-2-specific peptides either derived from the ACE2 protein via computational design and/or affinity selection 28 , 29 or screened from the mRNA display library. 30 As the RBD is highly exposed outside the viral spike, it is a good target for screening against the phage display peptide library to obtain a potentially sensitive peptide for SARS-CoV-2 virus detection.…”
Section: Introductionmentioning
confidence: 99%
“…Several precedent works that used RBD directly for the identification of peptide ligands have been reported; however, many of the identified ligands bound the RBD at locations distal to the RBD-ACE2 binding interface, and were therefore not productive at inhibiting the RBD-ACE2 interaction. 27,28 To avoid the identification of nonproductive peptide ligands, we reasoned that using small RBD epitopes that directly interact with ACE2 for the selection of phagedisplayed macrocyclic peptides will increase the chances of identifying productive macrocyclic peptide ligands that directly block interactions between RBD and ACE2. In this work, we report the successful implementation of this approach for the identification of a potent peptidyl SARS-CoV-2 antiviral and its validation.…”
Section: Figurementioning
confidence: 99%